Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
23.86
+0.73 (3.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
Spyre Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -214.9 | -338.79 | -83.82 | -65.8 | -80.89 | -78.25 | Upgrade
|
| Depreciation & Amortization | - | 0.96 | 1.96 | 2 | 1 | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | -1.84 | -15.53 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 132.77 | - | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -10.69 | -2.32 | -0.33 | 0.55 | 0.07 | -0.82 | Upgrade
|
| Stock-Based Compensation | 52.89 | 25.68 | 7.11 | 8.04 | 6.26 | 4.88 | Upgrade
|
| Other Operating Activities | 40.49 | 102.53 | 0.43 | -0.34 | 0.33 | 0.98 | Upgrade
|
| Change in Accounts Receivable | 0.16 | 0.38 | 0.44 | -0.82 | - | - | Upgrade
|
| Change in Accounts Payable | -9.54 | 0.22 | -2.64 | 1.07 | -0.54 | 2.58 | Upgrade
|
| Change in Unearned Revenue | - | 0.58 | -0.88 | 3.58 | - | - | Upgrade
|
| Change in Other Net Operating Assets | -7.82 | -6.37 | -2.42 | -1.99 | -2 | 4.52 | Upgrade
|
| Operating Cash Flow | -151.25 | -99.91 | -80.14 | -53.72 | -75.78 | -65.69 | Upgrade
|
| Capital Expenditures | - | - | -0.04 | -0.57 | -4.28 | -1.49 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.48 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | 3.04 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | 15 | - | - | - | - | Upgrade
|
| Investment in Securities | -218.01 | -126.9 | 57.05 | -22.05 | -3.32 | -0.25 | Upgrade
|
| Investing Cash Flow | -218.01 | -108.39 | 57.01 | -22.62 | -7.6 | -1.74 | Upgrade
|
| Long-Term Debt Repaid | - | -0.02 | -0.42 | -0.51 | -0.02 | -0.03 | Upgrade
|
| Net Debt Issued (Repaid) | - | -0.02 | -0.42 | -0.51 | -0.02 | -0.03 | Upgrade
|
| Issuance of Common Stock | 102.8 | 84.96 | 43.1 | 1.9 | 154.53 | 65.75 | Upgrade
|
| Other Financing Activities | -7.29 | -5.79 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 348.91 | 361.08 | 42.68 | 1.39 | 154.51 | 65.72 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | 0.03 | -0.11 | -0.02 | 0.05 | - | Upgrade
|
| Net Cash Flow | -20.32 | 152.8 | 19.44 | -74.96 | 71.18 | -1.71 | Upgrade
|
| Free Cash Flow | -151.25 | -99.91 | -80.18 | -54.29 | -80.06 | -67.18 | Upgrade
|
| Free Cash Flow Margin | - | -11276.52% | -3442.77% | -289.71% | - | - | Upgrade
|
| Free Cash Flow Per Share | -4.07 | -14.49 | -23.78 | -20.64 | -37.50 | -52.57 | Upgrade
|
| Levered Free Cash Flow | -60.86 | -9.61 | -50.01 | -30.62 | -50.8 | -39.06 | Upgrade
|
| Unlevered Free Cash Flow | -60.86 | -9.61 | -50.01 | -30.62 | -50.8 | -39.06 | Upgrade
|
| Change in Net Working Capital | -8.17 | -22.26 | 6.06 | -0.95 | 2.84 | -7.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.